课题基金 / 基金详情

项目摘要

项目成果

URSULA Anne MATULONIS的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要/摘要- Dana-Farber/哈佛癌症中心(DF/HCC)卵巢癌的总体目标SPORE 发展研究计划(DRP)是支持高风险/高潜力的试点项目, 最大限度地利用DF/HCC卵巢癌孢子内的新研究机会, 在整个资助期内维持本计划。甄选和监测过程将由以下人员领导: DRP董事,Ursula Matulonis博士,Stephen Cannistra和Alan D 'Andrea,另一位负责监督 孢子领导人斯普里格斯博士DF/HCC卵巢癌DRP执行委员会(EC) 包括DF/HCC SPORE委员会、外部咨询委员会、内部咨询委员会(IAB) 和卵巢癌倡导核心这个卵巢癌孢子项目将直接参与 DRP项目的评审、评分和选择。DRP将鼓励少数民族的申请, 妇女以及高风险/高回报项目。完全访问DF/HCC卵巢癌SPORE资源 包括核心访问将提供给DRP项目。这些项目已经证明了伟大的 进展和转化研究潜力将有可能成为完整的SPORE项目,但只有 DF/HCC卵巢癌DRP EC批准。减贫计划的部分经费来自 卵巢癌孢子预算以及从DF/HCC机构显着。
英文摘要
PROJECT SUMMARY/ABSTRACT - DEVELOPMENTAL RESEARCH PROGRAM RESEARCH PLAN The overall goals of the Dana-Farber/Harvard Cancer Center (DF/HCC) Ovarian Cancer SPORE Developmental Research Program (DRP) are to support high risk/high potential pilot projects that take maximum advantage of new research opportunities within the DF/HCC Ovarian Cancer SPORE and to maintain this Program throughout the entire grant term. The selection and monitoring process will be led by the DRP Directors, Drs. Ursula Matulonis, Stephen Cannistra and Alan D’Andrea, with oversight from the other SPORE leader, Dr. Spriggs. The DF/HCC Ovarian Cancer DRP Executive Committee (EC) which is comprised on the DF/HCC SPORE committee, the External Advisory Board, the Internal Advisory Board (IAB) and the Ovarian Cancer Advocate Core of this Ovarian Cancer SPORE Project will directly participate in the review, scoring and selection of DRP Projects. The DRP will encourage applications from minorities and women as well as high risk/high payoff projects. Full access to DF/HCC Ovarian Cancer SPORE resources including Core access will be available to DRP Projects. Those projects that have demonstrated great progress and translational research potential will have the potential to become full SPORE Projects but only with the approval of the DF/HCC Ovarian Cancer DRP EC. Funding for the DRP is comprised partly from the Ovarian Cancer SPORE budget as well as significantly from DF/HCC institutions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program (DRP)
  • 批准号:
    10469378
  • 项目类别:
  • 资助金额:
    $29.44万
  • 财政年份:
    2020
  • 负责人:
    URSULA Anne MATULONIS
  • 依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
  • 批准号:
    10024420
  • 项目类别:
  • 资助金额:
    $42.92万
  • 财政年份:
    2020
  • 负责人:
    URSULA Anne MATULONIS
  • 依托单位:
Developmental Research Program (DRP)
  • 批准号:
    10684241
  • 项目类别:
  • 资助金额:
    $14.97万
  • 财政年份:
    2020
  • 负责人:
    URSULA Anne MATULONIS
  • 依托单位:
Evaluation of the Efficacy of Trametinib + Navitoclax in recurrent ovarian carcinoma
  • 批准号:
    10228054
  • 项目类别:
  • 资助金额:
    $38.55万
  • 财政年份:
    2020
  • 负责人:
    URSULA Anne MATULONIS
  • 依托单位:
国内基金
海外基金
多模态超声VisTran-Attention网络评估早期子宫颈癌保留生育功能手术可行性
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郑巧
  • 依托单位:
Ultrasomics-Attention孪生网络早期精准评估肝内胆管癌免疫治疗的研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    陈立达
  • 依托单位: